Boston, MA -- (SBWIRE) -- 07/09/2013 -- GBI Research, the leading business intelligence provider, has released its latest research "Taiwan Pharmaceutical Market Outlook 2013". The report focuses on the Taiwanese pharmaceutical market, providing market analysis and a forecast to 2018. It provides details on the various market drivers and healthcare trends that influence growth in Taiwan's pharmaceutical industry. The report also profiles major biopharmaceutical companies in the country, both domestic and overseas players.

Taiwan's pharmaceutical market was worth $4.4 billion in 2012, having grown at a CAGR of 2.9%, and is estimated to reach $5.5 billion by 2018, growing at a CAGR of 3.9%. Although the size of the market is small compared with other growing markets in Asia, it is expected to provide a market entry point for companies wishing to launch their products in other larger markets.

View Full Report Details and Table of Contents

Scope

- Political, economic and investment environment in Taiwan
- Healthcare and insurance system, healthcare infrastructure and key policy initiatives
- Market size estimation, analysis of key therapeutic areas and emerging areas
- Profiles of major biopharmaceutical companies in Taiwan, such as Pfizer, Sanofi Aventis, GSK and Novartis, and key domestic players such as China Chemical & Pharmaceutical Company, Standard Chemicals & Pharmaceuticals and Yung Shin Pharmaceutical.
- Key drivers and barriers that have had a significant impact on the market

Reasons to Get This Report

- Identify potential therapeutic areas in Taiwan that are poised for growth
- Build effective market entry and expansion strategies for introducing products in Taiwan
- Develop key strategic initiatives by studying top competitors' key strategies
- Reinforce R&D pipelines by identifying new target mechanisms that can produce first-in-class molecules with more efficacy and better safety

Companies Mentioned in this Report: Pfizer, Sanofi, Novartis, GlaxoSmithKline, The China Chemical & Pharmaceutical Company, Standard Chemicals & Pharmaceuticals Co. Ltd., Yung Shin Pharmaceutical. Ind. Co. Ltd., ScinoPharm Taiwan, TTY Biopharm Company Limited

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- South Korea Pharmaceutical Market Outlook 2013
- Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
- Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
- Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
- Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
- Market Growth Outlook in the Pharmaceutical Industry - 2012-2013 : Survey Brief
- Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
- Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
- Business Indicators in the Pharmaceutical Industry - 2012-2013 : Survey Brief
- Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment